These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16401486)

  • 1. American Gastroenterological Association technical review on the management of hepatitis C.
    Dienstag JL; McHutchison JG
    Gastroenterology; 2006 Jan; 130(1):231-64; quiz 214-7. PubMed ID: 16401486
    [No Abstract]   [Full Text] [Related]  

  • 2. American Gastroenterological Association medical position statement on the management of hepatitis C.
    Dienstag JL; McHutchison JG
    Gastroenterology; 2006 Jan; 130(1):225-30. PubMed ID: 16401485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic hepatitis C with repeatedly normal transaminase levels].
    Dhumeaux D; Hézode C
    Rom J Gastroenterol; 2002 Jun; 11(2):129-33. PubMed ID: 12145669
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic Hepatitis C: a smart coat over a ragged dress?
    Gaeta GB
    Dig Liver Dis; 2009 Jul; 41(7):465-6. PubMed ID: 19410521
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis, management, and treatment of hepatitis C.
    Strader DB; Wright T; Thomas DL; Seeff LB;
    Hepatology; 2004 Apr; 39(4):1147-71. PubMed ID: 15057920
    [No Abstract]   [Full Text] [Related]  

  • 6. Alcohol and hepatitis C: do we have a drinking problem?
    Everhart JE
    Gastroenterology; 2006 May; 130(6):1912-4. PubMed ID: 16697753
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C and renal transplantation: a review on historical aspects and current issues.
    Moghaddam SM; Alavian SM; Kermani NA
    Rev Med Virol; 2008; 18(6):375-86. PubMed ID: 18702126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is {beta}-interferon a promising therapeutic option for the management of hepatitis C?
    Hosseini-Moghaddam SM; Mousavi A; Alavian SM
    J Antimicrob Chemother; 2009 Jun; 63(6):1097-103. PubMed ID: 19329508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatitis C in children: natural history and prognosis].
    Bortolotti F
    Recenti Prog Med; 2009 Feb; 100(2):97-102. PubMed ID: 19350803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded hepatitis C virus screening recommendations promote opportunities for care and cure.
    Ngo-Metzger Q; Ward JW; Valdiserri RO
    Ann Intern Med; 2013 Sep; 159(5):364-5. PubMed ID: 23797155
    [No Abstract]   [Full Text] [Related]  

  • 11. New drugs make treating hepatitis C faster and easier. In a minority of men, unchecked hepatitis C infection leads to liver damage or cancer. These drugs can quash the virus.
    Harv Mens Health Watch; 2014 Jul; 18(12):5. PubMed ID: 25219004
    [No Abstract]   [Full Text] [Related]  

  • 12. Virological relapse in chronic hepatitis C.
    Poordad FF; Flamm SL
    Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of chronic hepatitis C in 2008].
    Pol S; Marcellin P
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S121-4. PubMed ID: 18675182
    [No Abstract]   [Full Text] [Related]  

  • 14. Should you be tested for hepatitis C? New treatments promise high cure rates with fewer side effects. But carefully consider the pros and cons of testing.
    Harv Mens Health Watch; 2012 Sep; 17(2):6. PubMed ID: 23050283
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefit vs. harm of treatment of chronic hepatitis C.
    Steinberg J
    Am Fam Physician; 2005 Apr; 71(8):1489; author reply 1489-90. PubMed ID: 15864891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis.
    Sanyal AJ; Fontana RJ; Di Bisceglie AM; Everhart JE; Doherty MC; Everson GT; Donovan JA; Malet PF; Mehta S; Sheikh MY; Reid AE; Ghany MG; Gretch DR; Halt-C Trial Group
    Gastrointest Endosc; 2006 Dec; 64(6):855-64. PubMed ID: 17140886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis.
    Murray KF; Shah U; Mohan N; Heller S; González-Peralta RP; Kelly D; Chang MH; Mieli-Vergani G; Jara P; Fujisawa T;
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):225-33. PubMed ID: 18664880
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.
    Chevaliez S; Pawlotsky JM
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1031-48. PubMed ID: 19187865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.